phosphoinositide 3-kinase

May 2, 2016May 2, 2016

New PI3K Delta Inhibitor to Treat Blood Cancers Shows Promise in Early Clinical Study

News

MEI Pharma recently presented promising clinical results from a new oral phosphatidylinositol 3 kinase (PI3K) delta inhibitor, ME-401, that may improve the therapeutic window in cancer patients compared to other PI3K ... Read more

December 2, 2015December 2, 2015

Lymphoma Study Traces 2 Key Players’ Opposing Roles in B Cell Development

News

In a new study, scientists discovered that two key players in B cells, PI3 Kinase and FOXO1, have opposing roles in controlling B cell proliferation and differentiation in germinal centers, with implications ... Read more